alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

109TH CONGRESS 

1ST SESSION H. R. 2161 

To suspend temporarily the duty on 1,2 Pentanediol. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 5, 2005 

Mr. BROWN of South Carolina introduced the following bill; which was 

referred to the Committee on Ways and Means 

A BILL 

To suspend temporarily the duty on 1,2 Pentanediol. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 1,2 PENTANEDIOL. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following: 

‘‘ 9902.34.33 1,2 Pentanediol (CAS No. 

5343–02–0) (provided for in 

subheading 2905.39.90) ...... Free No change No change On or before 

12/31/2008 ’’. 

7 (b) EFFECTIVE DATE.—The amendment made by 

8 subsection (a) applies to goods entered, or withdrawn from 
2 

•HR 2161 IH 

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ
/ 

### fl ,/ Joan F. M. Malone, Plaintiff,
v. Former President George Bush Sr. 

### et al., Defendants. UNITED STATES DISTRICT COURT FORTHE DISTRICT OF COLUMBIA ) ) ) ) ) ) ) ) ) ) ) ) Civil Action No.

MEMORANDUM OPINION 

# FILED NOV - 52010 Clerk, U.S. District &Bankruptcy Courts for the District of Columbia 

# 10 

# 1902

This matter is before the Court on its initial review ofplaintiffs 

### pro se complaint and application for leave to proceed 

### informapauperis. The Court will grant the 

### informapauperis application and dismiss the case because the complaint fails to meet the minimal pleading requirements ofRule 8(a) ofthe Federal Rules ofCivil Procedure and is frivolous. 

### Pro se litigants must comply with the Federal Rules ofCivil Procedure. 

### Jarrell v. 

### Tisch, 656 F. Supp. 237, 239 (D.D.C. 1987). Rule 8(a) ofthe Federal Rules ofCivil Procedure requires complaints to contain "(1) a short and plain statement ofthe grounds for the court'sjurisdiction [and] (2) a short and plain statement ofthe claim showing that the pleader is entitled to relief." Fed. R. Civ. P. 8(a); 

### seeAshcroft v. 

### Iqbal, 129 S.Ct. 1937, 1950 (2009); 

### Ciralsky v. 

### CIA, 355 F.3d 661,668-71 (D.C. Cir. 2004). The Rule 8 standard ensures that defendants receive fair notice ofthe claim being asserted so that they can prepare a responsive answer and an adequate defense and determine whether the doctrine of

### resjudicata applies. 

### Brown v. 

### Califano, 75 F.R.D. 497,498 (D.D.C. 1977)
..

### Plaintiff, a District ofColumbia resident, sues former President George H.W. Bush, other former high-level officials and District ofColumbia Mayor Adrian Fentybut for what conduct is unknown. The complaint, consisting mostly ofdisjointed words and phrases, fails to provide any notice ofa claim and is simply frivolous. 1 

### A separate Order ofdismissal accompanies this Memorandum Opinion.

Date:

# November~, 2010

1 

### This complaint is one offive such submissions received by the Clerk's Office on the same day. Each complaint names a different set ofdefendants but is otherwise the same. Moreover, the Court recently dismissed another ofplaintiffs complaints as frivolous. Malone 

### v. 

# us. President Barack Obama, 

### No. 10-1826 (D.D.C. Oct. 28, 2010). Plaintiffis warned that her persistence in filing similar lawsuits may result in the Court imposing restrictions on her ability to file cases in this Court. 2
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2144 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 2144

    To suspend temporarily the duty on Cobaltate(1-), bis[3-[[1-(3- 
  chlorophenyl)-4,5-dihydro-3- methyl-5-(oxo-.kappa.O)-1H- pyrazol-4-
yl]azo-.kappa.N1]-4-. (hydroxy-.kappa.O)- benzenesulfonamid- ato(2-)]-, 
                                sodium.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 5, 2005

  Mr. Berry introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on Cobaltate(1-), bis[3-[[1-(3- 
  chlorophenyl)-4,5-dihydro-3- methyl-5-(oxo-.kappa.O)-1H- pyrazol-4-
yl]azo-.kappa.N1]-4-. (hydroxy-.kappa.O)- benzenesulfonamid- ato(2-)]-, 
                                sodium.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. COBALTATE(1-), BIS[3-[[1-(3- CHLOROPHENYL)-4,5-DIHYDRO-3- 
              METHYL-5-(OXO-.KAPPA.O)-1H- PYRAZOL-4-YL]AZO-.KAPPA.N1]-
              4- (HYDROXY-.KAPPA.O)- BENZENESULFONAMID- ATO(2-)]-, 
              SODIUM.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.05.55       Cobaltate(1-),     Free         No change        No change        On or before 12/  ''.
                         bis[3-[[1-(3-                                                      31/2008
                         chlorophenyl)-4,5-
                         dihydro-3- methyl-
                         5-(oxo-.kappa.O)-
                         1H- pyrazol-4-
                         yl]azo-.kappa.N1]-
                         4- (hydroxy-
                         .kappa.O)-
                         benzenesulfonamid-
                          ato(2-)]-,
                         sodium (CAS No.
                         73612-40-5)
                         (provided for in
                         subheading
                         3204.12.45)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
[Federal Register Volume 60, Number 92 (Friday, May 12, 1995)]
[Notices]
[Page 25704]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11805]



-----------------------------------------------------------------------


DEPARTMENT OF ENERGY

Environmental Management Site-Specific Advisory Board, Monticello 
Site

AGENCY: Department of Energy.

ACTION: Notice of Open Meeting.

-----------------------------------------------------------------------

SUMMARY: Pursuant to the provisions of the Federal Advisory Committee 
Act (Pub. L. 92-463, 86 Stat. 770) notice is hereby given of the 
following Advisory Board Committee Meeting: Environmental Management 
Site-Specific Advisory Board, Monticello Site.

DATES AND TIMES: Tuesday, May 16, 1995 6:30 p.m.-8:00 p.m.

ADDRESSES: Monticello City Hall, Monticello, Utah 84535.

FOR FURTHER INFORMATION CONTACT: Audrey Berry, Public Affairs 
Specialist, Department of Energy Grand Junction Projects Office, P.O. 
Box 2567, Grand Junction, CO, 81502 (303) 248-7727.

SUPPLEMENTARY INFORMATION:

Purpose of the Board

    The purpose of the Board is to advise DOE and its regulators in the 
areas of environmental restoration, waste management, and related 
activities.

Tentative Agenda

    The Environmental Management Site-Specific Advisory Board, 
Monticello Site, will be discussing issues related to the 
reorganization of the advisory board.

Public Participation

    The meeting is open to the public. Written statements may be filed 
with the Committee either before or after the meeting. Individuals who 
wish to make oral statements pertaining to agenda items should contact 
Audrey Berry's office at the address or telephone number listed above. 
Requests must be received 5 days prior to the meeting and reasonable 
provision will be made to include the presentation in the agenda. The 
Designated Federal Official is empowered to conduct the meeting in a 
fashion that will facilitate the orderly conduct of business. Each 
individual wishing to make public comment will be provided a maximum of 
5 minutes to present their comments. This notice is being published 
less than 15 days before the date of the meeting, due to programmatic 
issues that had to be resolved prior to publication.

Minutes

    The minutes of this meeting will be available for public review and 
copying at the Freedom of Information Public Reading Room, 1E-190, 
Forrestal Building, 1000 Independence Avenue, SW, Washington, DC 20585 
between 9:00 a.m. and 4 p.m., Monday-Friday, except Federal holidays. 
Minutes will also be available by writing to Audrey Berry, Department 
of Energy Grand Junction Projects Office, P.O. Box 2567, Grand 
Junction, CO 81502, or by calling her at (303)-248-7727.

    Issued at Washington, DC on May 9, 1995.
Rachel M. Samuel,
Acting Deputy Advisory Committee Management Officer.
[FR Doc. 95-11805 Filed 5-11-95; 8:45 am]
BILLING CODE 6450-01-P
Exhibit 10.13

July 25, 2002

Mr. David M. Davis
2390 Woodglen Drive
Aurora, IL 60504

Dear Dave:

As you know, US Airways, Inc. (the "Company") is implementing a financial restructuring designed to significantly reduce its operating costs (the "2002 Restructuring Program"). Part of the 2002 Restructuring Program involves changes in the compensation and benefits programs of all employees, including officers. Specifically, pursuant to this 2002 Restructuring Program:

1. your salary will be reduced by 13.5%;

2. your vacation time will be reduced by one week during the first year of the program and will be capped at a maximum of 5 weeks thereafter;

3. annual sick leave accrual will be reduced from 12 to 11 days by eliminating the accrual for August;

4. US Airways' health plan coverage will be changed to one national medical PPO and dental plan and your contribution rate for such plans will be established by the Company and may be increased from time to time;

5. you will not receive any payments pursuant to the Incentive Compensation Plan for fiscal years 2002 and 2003;

6. you will not receive any payments pursuant to the Long Term Incentive Plan for performance periods ending with fiscal years 2002 and 2003; and

7. your split dollar life insurance benefit, long term disability benefit and supplemental retirement arrangement will be based upon your salary of record immediately prior to the reduction of your salary.

You agree that (1) the foregoing actions will not, either separately or in the aggregate, constitute "Good Reason", as such term is defined in the Severance Agreement entered into as of April 8, 2002 between you and the Company (the "Agreement"), (2) Section 6 of the Agreement shall be applied as if your salary was not reduced as described in paragraph 1 above and (3) if, pursuant to the Agreement, you become entitled to continuation of health benefits following your termination of employment, the benefits to which you will be entitled will be provided on the same basis as such benefits are provided to active vice presidents of the Company, and as such benefits may be amended from time to time.

As applicable, this letter will be deemed to constitute a written amendment to your Agreement.

Please acknowledge your agreement to the foregoing by signing this letter in the space provided below and returning it to me.

Sincerely,



Jennifer C. McGarey

AGREED TO AND ACCEPTED

---------------------------

David M. Davis
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2173 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 2173

           To suspend temporarily the duty on 1,2 Hexanediol.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 5, 2005

 Mr. Brown of South Carolina introduced the following bill; which was 
              referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
           To suspend temporarily the duty on 1,2 Hexanediol.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1,2 HEXANEDIOL.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following:

``      9902.34.31       1,2 Hexanediol     Free         No change        No change        On or before 12/  ''.
                         (CAS No. 6920-22-                                                  31/2008
                         5) (provided for
                         in subheading
                         2905.39.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
#### The People of the State of New York, Respondent, v Philip Schron, Appellant.

— Appeal by defendant from a judgment of the Supreme Court, Queens County (Rotker, J.), rendered January 30,1984, convicting him of criminal possession of a controlled substance in the second degree, upon his plea of guilty, and sentencing him to an indeterminate term of imprisonment of six years to life.

Judgment affirmed.

On this appeal, the defendant contends that his plea of guilty should be vacated since he whs not advised, at the taking of the plea, of his rights to testify on his own behalf and to have the jury’s verdict be unanimous before he could be convicted. Having failed either to move to withdraw his plea on this ground *763prior to the imposition of sentence or subsequent thereto pursuant to CPL 440.10, the defendant has not preserved for appellate review the sufficiency of the plea allocution *(see,*CPL 470.05 [2]; *People v Hoke,*62 NY2d 1022; *People v Pellegrino,*60 NY2d 636; *People v Mattocks,*100 AD2d 944; *People v Ortiz,*105 AD2d 809). In any event, were we to review this issue in the interest of justice, vacatur would not be required inasmuch as the allocution satisfied the requirements of *People v Harris*(61 NY2d 9; *see, People v Velasquez,*107 AD2d 726).

Nor is there any merit to the defendant’s claim that his sentence, which was imposed in accordance with the plea agreement *(see, People v La Lande,*104 AD2d 1052; *People v Nelson,*104 AD2d 1055; *People v Kazepis,*101 AD2d 816), was unduly harsh and excessive. Moreover, we find no basis to modify the sentence in the interest of justice *(see, People v Suitte,*90 AD2d 80). Gibbons, J. P., Weinstein, Brown and Eiber, JJ., concur.
#### BURGEYIN, Respondent, v. BONSALL, Appellant.

(Supreme Court, Appellate Division, Second Department.

April 4, 1912.)

Action by Paul J. Burgevin against Seymour W. Bonsall.

PER CURIAM.

Order of the County Court of Westchester County modified, so as to require plaintiff to serve a bill of particulars, which shall state what articles were furnished, what work was performed, and, as nearly as practicable, the time of such performance, without costs of the motion, and, as so modified, order affirmed, without costs.
<TABLE> <S> <C>

<ARTICLE> 5
<CIK>0000701345 
<NAME>US AIRWAYS GROUP, INC. 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                       1,135,750
<SECURITIES>                                   482,118
<RECEIVABLES>                                  408,077<F1>
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                    238,065
<CURRENT-ASSETS>                             2,404,581
<PP&E>                                       6,413,105
<DEPRECIATION>                               2,599,954
<TOTAL-ASSETS>                               7,514,295
<CURRENT-LIABILITIES>                        2,587,716
<BONDS>                                      2,546,146
<PREFERRED-MANDATORY>                          358,000
<PREFERRED>                                    213,128
<COMMON>                                        80,111
<OTHER-SE>                                   (372,473)
<TOTAL-LIABILITY-AND-EQUITY>                 7,514,295
<SALES>                                              0
<TOTAL-REVENUES>                             4,313,688
<CGS>                                                0
<TOTAL-COSTS>                                3,822,516
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             128,685
<INCOME-PRETAX>                                397,338
<INCOME-TAX>                                    39,094
<INCOME-CONTINUING>                            358,244
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   358,244
<EPS-PRIMARY>                                     4.48
<EPS-DILUTED>                                     3.37
<FN>
<F1>Receivables are presented net of allowances.
</FN>
        

</TABLE>
----

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

| Dated:                April 17, 2006 |                                                                                         |
|--------------------------------------|----------------------------------------------------------------------------------------------|
|                                 |                                                                                         |
|                                 |                                                                                         |
|                                 |                                                                                         |
|                                 | /                s                / Darrell Parlee                                           |
|                                 |                                                                                         |
|                                 | Darrell                Parlee                                                                |
|                                 | Treasurer                and Director                                                        |
|                                 | (Principal                Financial Officer and Principal Accounting                Officer) |

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
      ( print page 33329)    
*Name of Committee:*                         Biomedical Informatics, Library and Data Sciences Review Committee (BILDS).                    

*Date:*                         November 4, 2021.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Contact Person:*                         Zoe E. Huang, MD, Chief Scientific Review Officer, Scientific Review Office, Extramural Programs, National Library of Medicine, National Institutes of Health (NIH), 6705 Rockledge Drive, Suite 500, Bethesda, MD 20892-7968, 301-594-4937,                         *huangz@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS)

Dated: June 14, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-13356 Filed 6-23-21; 8:45 am]

BILLING CODE 4140-01-P
Antonio VALDEZ, petitioner, v. UNITED STATES.

No. 13-6941.

Supreme Court of the United States

Nov. 18, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.